Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour markerPeter Canney(Beatson West of Scotland Cancer Centre), R.D. James(University of Kent)British Journal of CancerDecember 1, 198410.1038/bjc.1984.254Cited by 319SaveCiteExport RISWatch citationsRelated PapersCardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials|BMC Cancer|2010|755